Coherus BioSciences Prices 3.5 Million Shares At $18.00/Share

By: via Benzinga
Coherus BioSciences Inc (NASDAQ: CHRS), a leading pure-play, global biosimilars company with late-stage clinical products, revealed ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.